Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
3,900.62
6,046.87
3,264.44
3,256.20
3,387.55
3,433.80
3,244.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,900.62
6,046.87
3,264.44
3,256.20
3,387.55
3,433.80
3,244.18
Raw Material Cost
775.30
722.50
732.47
794.78
746.37
774.36
685.77
Purchase of Finished goods
748.56
620.45
581.34
344.74
418.15
443.08
360.03
(Increase) / Decrease In Stocks
-228.76
-78.44
-298.23
-50.57
-80.28
-147.36
64.28
Employee Cost
841.40
1,086.26
762.75
736.57
788.49
786.57
710.44
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
894.36
1,336.55
905.59
869.66
914.59
975.23
835.45
Total Expenditure (Excl Depreciation)
3,030.86
3,687.32
2,683.92
2,695.18
2,787.32
2,831.88
2,655.97
Operating Profit (PBDIT) excl Other Income
869.76
2,359.55
580.52
561.02
600.23
601.92
588.21
Other Income
44.47
200.63
26.44
11.69
31.13
39.42
31.49
Operating Profit (PBDIT)
914.23
2,560.18
606.96
572.71
631.36
641.34
619.70
Interest
41.43
66.46
58.23
66.71
52.29
48.48
39.58
Exceptional Items
-184.34
-1,385.12
-323.23
-372.82
0.00
0.00
0.00
Gross Profit (PBDT)
688.46
1,108.60
225.50
133.18
579.07
592.86
580.12
Depreciation
154.45
141.20
129.93
125.21
122.74
120.28
117.79
Profit Before Tax
534.00
967.40
95.58
7.97
456.33
472.57
462.33
Tax
130.77
356.97
48.61
3.59
108.30
118.09
122.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
403.23
610.43
46.97
4.38
348.03
354.49
340.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
403.23
610.43
46.97
4.38
348.03
354.49
340.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.02
0.08
0.10
-0.27
0.07
0.27
-0.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
403.21
610.35
46.87
4.65
347.96
354.21
340.27
Equity Capital
28.22
28.22
28.22
28.22
28.22
28.22
28.22
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
14.29
21.63
1.66
0.16
12.33
12.55
12.06
Diluted Earnings per share
14.28
21.62
1.66
0.16
12.33
12.55
12.06
Operating Profit Margin (Excl OI)
22.37%
39.3%
18.98%
17.42%
18.18%
17.7%
18.25%
Gross Profit Margin
17.71%
18.47%
7.37%
4.14%
17.54%
17.43%
18.0%
PAT Margin
10.37%
10.17%
1.54%
0.14%
10.54%
10.42%
10.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -35.49% vs 85.23% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -33.94% vs 1,202.22% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -63.14% vs 306.45% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -37.66% vs 14.13% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Glenmark Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
3,900.62
0
3,900.62
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,900.62
0
3,900.62
Raw Material Cost
775.30
0
775.30
Purchase of Finished goods
748.56
0
748.56
(Increase) / Decrease In Stocks
-228.76
0
-228.76
Employee Cost
841.40
0
841.40
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
894.36
0.00
894.36
Total Expenditure (Excl Depreciation)
3,030.86
0
3,030.86
Operating Profit (PBDIT) excl Other Income
869.76
0.00
869.76
Other Income
44.47
0
44.47
Operating Profit (PBDIT)
914.23
0
914.23
Interest
41.43
0
41.43
Exceptional Items
-184.34
0
-184.34
Gross Profit (PBDT)
688.46
0
688.46
Depreciation
154.45
0
154.45
Profit Before Tax
534.00
0
534.00
Tax
130.77
0
130.77
Provisions and contingencies
0.00
0
0.00
Profit After Tax
403.23
0
403.23
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
403.23
0
403.23
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.02
0
0.02
Other related items
0.00
0.00
0.00
Consolidated Net Profit
403.21
0
403.21
Equity Capital
28.22
0
28.22
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
14.29
0
14.29
Diluted Earnings per share
14.28
0
14.28
Operating Profit Margin (Excl OI)
22.37%
0%
0.00
22.37%
Gross Profit Margin
17.71%
0%
0.00
17.71%
PAT Margin
10.37%
0%
0.00
10.37%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,900.62 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -35.49% vs 85.23% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 15.15% vs 35.14% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 403.21 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -33.94% vs 1,202.22% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 15.88% vs 199.03% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 869.76 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -63.14% vs 306.45% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 44.90% vs 387.67% in Dec 2024
Quarterly - Interest
Interest 41.43 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -37.66% vs 14.13% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -20.77% vs -61.08% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.37%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
